BORDEAUX, France & BOSTON--(BUSINESS WIRE )--Regulatory News:
IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants, announced today the signing of an agreement defining
Stryker Corporation found using ticker (SYK) have now 21 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 305 and 239 with the average target price sitting at 283. With the stocks
Permanent link to this press release:
Delete press release Edit press rele
Permanent link to this press release:
Delete press release Edit press rele
Please stand by, while we are checking your browser...
Please enable Cookies and reload the page.
Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.
If you are on a personal connection, like at home, you can run an anti-virus sca
AUSTIN, Texas, April 5, 2022 /PRNewswire/ — Ensemble Orthopedics Inc, a privately held company, today announced the 100th implantation of the Ensemble CMC™ minimally invasive joint replacement for the treatment of carpometacarpal (CMC or thumb) osteoarthritis, coinciding with
Hi, what are you looking for?
The Steadfast Orthopedic Implants Market Research Report presents the solutions that empower to arrive at smart, fast and precise decisions for the business so that it grows and surpasses their goals. The market research report is a demonstrated source of in
Hi, what are you looking for?
The Steadfast Orthopedic Implants Market Research Report presents the solutions that empower to arrive at smart, fast and precise decisions for the business so that it grows and surpasses their goals. The market research report is a demonstrated source of in
Accelus launched its TiHawk7 interbody cage for endoscopic and minimally invasive lumbar fusions.
The system is part of the devicemaker's FlareHawk interbody portfolio and has an ultra-low profile with titanium at the bony interface, according to a May 5 news release. The first case with
Analysis | By Kaiser Health News | August 10, 2021
Hundreds of orthopedists and neurosurgeons have cashed in on stakes in companies that design, manufacture or distribute orthopedic implants — sometimes after investing little or no money. Th